Lv76
4725 积分 2020-09-07 加入
Oral Semaglutide in an East Asian Population With Overweight or Obesity, With or Without Type 2 Diabetes: The OASIS 2 Randomized Clinical Trial
10天前
已完结
Oral Semaglutide in an East Asian Population With Overweight or Obesity, With or Without Type 2 Diabetes: The OASIS 2 Randomized Clinical Trial
10天前
已完结
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
10天前
已完结
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
10天前
已完结
FDA-approved drug labeling for the study of drug-induced liver injury
2个月前
已完结
Evaluation of Standard Response Assessment in Neuro-Oncology, Modified Response Assessment in Neuro-Oncology, and Immunotherapy Response Assessment in Neuro-Oncology in Newly Diagnosed and Recurrent Glioblastoma
2个月前
已完结
A Neuroradiologist's Guide to Operationalizing the Response Assessment in Neuro-Oncology (RANO) Criteria Version 2.0 for Gliomas in Adults
2个月前
已完结
RANO 2.0 criteria: concepts applicable to the neuroradiologist's clinical practice
2个月前
已完结
Updated Response Assessment in Neuro-Oncology (RANO) for Gliomas
2个月前
已完结
Tools and toys beyond RANO 2.0: Digital flipbooks to monitor brain tumor growth dynamics?
2个月前
已完结
皖公网安备34019202002308
